AIM HY

AIM HY Logo

  • Home
  • About AIM HY
  • Our research
    • Genetics
    • Biostatistics
    • Clinical Trial
    • Multi-omics
    • Mechanisms
    • Global Health
    • Health Economics
  • Consortium Members
  • Clinical Trial – AIM HY INFORM
    • Patients
    • The Patient Forum Comments Form
    • Staff
  • Publications
  • Contact Us
    • Online Contact Form
  • Internal

Biostatistics

Work Strand 2

 

Work Strand 2 Co-leads: Prof. Cathryn Lewis (King’s College London) and Dr Adrian Mander (MRC Centre Cambridge)

Prof. Cathryn Lewis
Dr Adrian Mander

AIM HY will generate large amounts of clinical, genetic and metabolomic data, which need sophisticated statistical analysis to ensure the research programme achieves its aims. Work Strand 2 will provide the necessary statistical methodology and analysis to support WS1, WS3 and subsequent work strands. Statistical genetics work from Professor Cathryn Lewis and Dr Raquel Iniesta at KCL is being focused on using data from the existing US clinical trials to develop panels of Ancestry Informative Markers, and to test whether ancestry that is genetically defined is a better predictor of response than self-defined ethnicity. The team will submit on early 2017 a scientific article about their last advances on this research. The biostatistics work from Dr Adrian Mander’s team at The MRC Biostatistics Unit aims to provide support to the design and analysis of the RCT in WS3, as well as the mechanistic and global WSs.

  • Home
  • About AIM HY
  • Our research
    • Genetics
    • Biostatistics
    • Clinical Trial
    • Multi-omics
    • Mechanisms
    • Global Health
    • Health Economics
  • Consortium Members
  • Clinical Trial – AIM HY INFORM
    • Patients
    • The Patient Forum Comments Form
    • Staff
  • Publications
  • Contact Us
    • Online Contact Form
  • Internal

The Patient Forum

Share your comments on “your life with hypertension” and/or your experience of AIM HY INFORM Clinical Trial.

"I was diagnosed with high blood pressure more than 10 years ago. In August 2015, I had a Coronary Angioplasty surgery when three stents were inserted in one of my heart's arteries. My symptoms improved a bit but not significantly. In August 2017, I saw an advert inviting people to participate in the AIM HY programme. I hurriedly offered myself as a guinea-pig. I have only started the first round of dual therapy and believe me, I am feeling so much better.
For the first time in many years, I ran to catch a bus without feeling short of breath. I have opted to be an ambassador of this programme because it is effective.
I want as many people particularly from the ethnic minorities to benefit."

If you would like to leave a comment related to your treatment or the AIM HY INFORM trial experience, please click here. 

Follow me on Twitter

My Tweets

BHF small

MRC - small 2
CU - small

UK small

KCL - small 3

QMUL - small

UF - small

Manchester - small 2

Mayo - small 2

UCL - small 3

Glasgow - small 2

Nottingham - small 2

Copyright © 2019 AIMHY . Internal